Goldman is said to be shutting two hedge funds run out of Asia
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[NEW YORK] Goldman Sachs Group Inc is shutting two hedge funds run by people based in Asia, according to people with knowledge of the matter.
The funds, which together manage about US$1.4 billion in assets, were run by Goldman Sachs partners Ryan Thall and Hideki Kinuhata, the people said, asking not to be identified because the information isn't public. Mr Kinuhata is retiring while Mr Thall is expected to start his own fund, the people said.
A spokesman for Goldman Sachs declined to comment. Mr Thall and Mr Kinuhata didn't immediately respond to messages seeking comment.
The two hedge funds operated under the Goldman Sachs Investment Partners division, which has about US$4 billion in assets, the bulk of which are private equity or venture capital types of investments. Hong Kong-based Thall and Tokyo-based Kinuhata made long-short equity bets in Asia and globally, the people said.
Part of the reason for the closures is fickle demand for such hedge fund-like products at a time when the industry has struggled to outperform benchmarks and investors are crowding alternative options to generate outsized returns.
Oryza Capital, the Asia-focused fund, managed about US$478 million and returned 0.6 per cent this year through July after gaining 19 per cent in 2017, according to a newsletter seen by Bloomberg News.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
Goldman Sachs had about US$150 billion globally in alternative investments spread across public and private markets as of the end of June.
BLOOMBERG
Share with us your feedback on BT's products and services
TRENDING NOW
Japan stocks look set for new highs in 2025 on earnings, reform
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant